Synthetic Trial Acceleration

Leveraging synthetic digital twins to simulate control arms, reducing recruitment needs and accelerating 2026 drug launch cycles.

The Bottleneck

Life sciences companies are experiencing extended clinical trial timelines and exorbitant patient recruitment costs. Fragmented longitudinal patient data makes establishing control arms nearly impossible.

Our Solution

We link encounter, claim, and clinical data into golden patient records. Using these unified data products, we simulate synthetic digital twins for control arms, drastically accelerating drug launch cycles.

Expected Engineering Outcomes

40% reduction in recruitment needs
HIPAA-compliant data mesh
Accelerated 2026 launch timelines

Execute this architecture

Ready to implement synthetic trial acceleration? Book a technical discovery call with our engineering team to review your current state.

Book Discovery Call